Article Type
Changed
Display Headline
Biomarker Testing for Relapsing-Remitting MS
MSPrecise tests use cerebrospinal fluid markers to predict RRMS

MSPrecise, a cerebrospinal fluid test to diagnose relapsing-remitting multiple sclerosis (RRMS), displays high accuracy rate in identifying RRMS patients, a study reports.  

Investigators tested cerebrospinal fluid pellets from patients with RRMS and other neurological diseases for the presence RRMS-enriched mutation patterns and found:

• 75% sensitivity in RRMS patients

• 88% specificity in other neurological diseases

• 84% accuracy for identifying RRMS patients or patients who will develop RRMS

Citation: Rounds WH, Salinas EA, Wilks TB 2nd, et al. MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing. Gene. 2015. pii: S0378-1119(15)00821-5. doi: 10.1016/j.gene.2015.07.011.

References

Author and Disclosure Information

Publications
Topics
Legacy Keywords
RRMS biomarker, MSPrecise
Author and Disclosure Information

Author and Disclosure Information

MSPrecise tests use cerebrospinal fluid markers to predict RRMS
MSPrecise tests use cerebrospinal fluid markers to predict RRMS

MSPrecise, a cerebrospinal fluid test to diagnose relapsing-remitting multiple sclerosis (RRMS), displays high accuracy rate in identifying RRMS patients, a study reports.  

Investigators tested cerebrospinal fluid pellets from patients with RRMS and other neurological diseases for the presence RRMS-enriched mutation patterns and found:

• 75% sensitivity in RRMS patients

• 88% specificity in other neurological diseases

• 84% accuracy for identifying RRMS patients or patients who will develop RRMS

Citation: Rounds WH, Salinas EA, Wilks TB 2nd, et al. MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing. Gene. 2015. pii: S0378-1119(15)00821-5. doi: 10.1016/j.gene.2015.07.011.

MSPrecise, a cerebrospinal fluid test to diagnose relapsing-remitting multiple sclerosis (RRMS), displays high accuracy rate in identifying RRMS patients, a study reports.  

Investigators tested cerebrospinal fluid pellets from patients with RRMS and other neurological diseases for the presence RRMS-enriched mutation patterns and found:

• 75% sensitivity in RRMS patients

• 88% specificity in other neurological diseases

• 84% accuracy for identifying RRMS patients or patients who will develop RRMS

Citation: Rounds WH, Salinas EA, Wilks TB 2nd, et al. MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing. Gene. 2015. pii: S0378-1119(15)00821-5. doi: 10.1016/j.gene.2015.07.011.

References

References

Publications
Publications
Topics
Article Type
Display Headline
Biomarker Testing for Relapsing-Remitting MS
Display Headline
Biomarker Testing for Relapsing-Remitting MS
Legacy Keywords
RRMS biomarker, MSPrecise
Legacy Keywords
RRMS biomarker, MSPrecise
Article Source

PURLs Copyright

Inside the Article